GDNF in treatment of Parkinson's disease: Response to editorial

Anthony E. Lang, J. William Langston, A. Jon Stoessl, Matthew Brodsky, David J. Brooks, Vijay Dhawan, William J. Elias, Andres M. Lozano, Elena Moro, John G. Nutt, Mark Stacy, Dennis Turner, G. Frederick Wooten, Richard D. Penn, Arif Dalvi, John Slevin, Byron Young, Don Gash, Greg Gerhardt, Michael Hutchinson

Research output: Contribution to journalLetter

31 Scopus citations
Original languageEnglish (US)
Pages (from-to)200-202
Number of pages3
JournalLancet Neurology
Volume5
Issue number3
DOIs
StatePublished - Mar 2006

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Lang, A. E., Langston, J. W., Stoessl, A. J., Brodsky, M., Brooks, D. J., Dhawan, V., Elias, W. J., Lozano, A. M., Moro, E., Nutt, J. G., Stacy, M., Turner, D., Wooten, G. F., Penn, R. D., Dalvi, A., Slevin, J., Young, B., Gash, D., Gerhardt, G., & Hutchinson, M. (2006). GDNF in treatment of Parkinson's disease: Response to editorial. Lancet Neurology, 5(3), 200-202. https://doi.org/10.1016/S1474-4422(06)70359-3